npj Vaccines

SJR Rank #1,118H-index: 63SJR: 2.282Best quartile: Q1Open AccessAPC: US$3,890Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Nature Research

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.81.62.43.2

Subject Categories

  • ImmunologyQ1
  • Infectious DiseasesQ1
  • PharmacologyQ1
  • Pharmacology (medical)Q1

Areas: Immunology and Microbiology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesInfluenza Virus Research StudiesMosquito-borne diseases and controlRespiratory viral infections researchViral gastroenteritis research and epidemiologyvaccines and immunoinformatics approachesViral Infections and VectorsAnimal Virus Infections StudiesViral Infections and Outbreaks Research

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025070140210280

Detailed Information

ISSN

2059-0105

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

6.81

References per Document

54.98

Coverage

2016-2026

Scope

npj Vaccines is a multidisciplinary journal that is dedicated to publishing the finest and high-quality research and development on human and veterinary vaccines, including: discovery and basic science, nonclinical development of vaccines, biodefense vaccine, AIDS vaccine, vaccine formulation, vaccine adjuvants and conjugate vaccines, cancer/oncology vaccines, clinical evaluation of vaccines, vaccine safety, regulatory science, conventional and non-conventional vaccines, live, attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vector vaccines.

Metrics from SCImago Journal Rank 2025. View on SCImago